Thymoma in Myasthenia Gravis: From Diagnosis to Treatment
One half of cortical thymoma patients develop myasthenia gravis (MG), while 15% of MG patients have thymomas. MG is a neuromuscular junction disease caused in 85% of the cases by acetylcholine receptor (AChR) antibodies. Titin and ryanodine receptor (RyR) antibodies are found in 95% of thymoma MG an...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
SAGE-Hindawi Access to Research
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155972/ |